Literature DB >> 9260240

Increased recognition of IgA nephropathy in African-American children.

A M Sehic1, L W Gaber, S Roy, P M Miller, S B Kritchevsky, R J Wyatt.   

Abstract

Based upon the percentage of cases of IgA nephropathy (IgAN) in biopsy series, a lower prevalence has been assumed for African-Americans compared with Americans of European descent. This may be due to a racial difference in the basic underlying pathology of IgAN or to racial differences in patterns of referral and biopsy selection practices. Over the past decade (1985-1994), we have found similar incidences of IgAN in Caucasian and African-American children from Shelby County, Tennessee. The incidence was 3.0 cases per million per year for Caucasian and 5.7 cases per million per year for African-American children. IgAN may be more common in African-American children than previously appreciated. Population-based incidence studies will be necessary to determine whether or not our experience has become a more widespread phenomenon.

Entities:  

Mesh:

Year:  1997        PMID: 9260240     DOI: 10.1007/s004670050311

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 2.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

3.  Epidemiological survey and clinical investigation of pediatric IgA nephropathy.

Authors:  Takayuki Shibano; Nobuaki Takagi; Kohei Maekawa; Hiromu Mae; Masuji Hattori; Yasuhiro Takeshima; Takakuni Tanizawa
Journal:  Clin Exp Nephrol       Date:  2015-06-04       Impact factor: 2.801

4.  Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.

Authors:  Dita Maixnerova; Eva Jancova; Jelena Skibova; Romana Rysava; Ivan Rychlik; Ondrej Viklicky; Miroslav Merta; Alexander Kolsky; Jana Reiterova; Michaela Neprasova; Jana Kidorova; Eva Honsova; Vladimir Tesar
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

5.  Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.

Authors:  M Colleen Hastings; Zina Moldoveanu; Bruce A Julian; Jan Novak; John T Sanders; Kim R McGlothan; Ali G Gharavi; Robert J Wyatt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 8.237

6.  Incidence of pediatric IgA nephropathy.

Authors:  Yasushi Utsunomiya; Takayuki Koda; Tadashi Kado; Sinichi Okada; Atsushi Hayashi; Susumu Kanzaki; Tsunakiyo Kasagi; Hiroshi Hayashibara; Teruo Okasora
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

Review 7.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

8.  IgA nephropathy in African Americans: uncommon but possible.

Authors:  Abhilash Koratala; William L Clapp; Don H Esprit; Jogiraju Tantravahi
Journal:  JRSM Open       Date:  2018-06-08

9.  The Usefulness of Vanin-1 and Periostin as Markers of an Active Autoimmune Process or Renal Fibrosis in Children with IgA Nephropathy and IgA Vasculitis with Nephritis-A Pilot Study.

Authors:  Małgorzata Mizerska-Wasiak; Emilia Płatos; Karolina Cichoń-Kawa; Urszula Demkow; Małgorzata Pańczyk-Tomaszewska
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

10.  New Insights into the Pathogenesis of IgA Nephropathy.

Authors:  Jan Novak; Dana Rizk; Kazuo Takahashi; XianWen Zhang; Qi Bian; Hirouki Ueda; Yoshimi Ueda; Colin Reily; Ling-Yun Lai; Chuanming Hao; Lea Novak; Zhi-Qiang Huang; Matthew B Renfrow; Hitoshi Suzuki; Bruce A Julian
Journal:  Kidney Dis (Basel)       Date:  2015-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.